Corino Therapeutics
New York, US · Founded 2016 · Delaware corporation
Founders & leadership
DD
Daniel DiPietroExecutive
Board
TM
Timothy McInerneyBoard director
JM
Jay MoorinBoard director
PB
Peter BarberBoard director
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2017
▶$3.5MraisedApr 2017 · 27 investors · BiotechnologyRule 506(b)
▶$3.5MraisedApr 2017 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy McInerneyDirector
- Daniel DiPietroExecutive Officer, Director
- Jay MoorinDirector
- Peter BarberDirector
- Offering amount
- $5M
- Amount sold
- $3.5M
- Sales commissions
- $208.4K
- Proceeds to insiders
- $208.4K
- Placement agents
- ROTH Capital Partners, Castle Hill Capital Partners, Inc.
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Corino Therapeutics raised?
- Corino Therapeutics has disclosed $3.5M raised across 1 round.
- Where is Corino Therapeutics headquartered?
- Corino Therapeutics is headquartered in New York, US.